|
|||||||||||||||
|
|||||||||||||||
New Jersey Family Policy Council PO Box 6011 Parsippany, NJ 07054 P: 800-653-7204 F: 888-453-6346 Click Here to Contact Us |
|||||||||||||||
 |
|
Letters to the Editor: In response to recent articles in support of the stem cell bond up for a vote in November, there are some important points missing that would more fully inform voters. One important development is that two major research entities Stowers Institute of Medical Research and University of Missouri have recently abandoned embryonic stem cell research due to the lack of success and ethical headaches. In fact even in Singapore, where embryonic research has been pursued, a former executive from ES Cell International says the company’s investors no longer want to back these experiments due to lack of a “clinical product”. A second very important development is there has been another major success with adult stem cells in a human patient, unbeknownst to those who read most NJ papers. In June, PBS featured an amazing account of a 58-yr-old woman who’s right side of her heart was only functioning at 50% and who had experience a fourth heart attack. After having 30 million adult stem cells cultivated from bone marrow on her hip, one year later her doctor reports her heart is “normal”. No such success stories can be found with embryonic stem cells, yet this is what voters are being told holds some unsubstantiated future promise. DISREGARD |
|
